<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00410020</url>
  </required_header>
  <id_info>
    <org_study_id>DGS 990321</org_study_id>
    <secondary_id>99-04 (CPPRB BORDEAUX B)</secondary_id>
    <nct_id>NCT00410020</nct_id>
  </id_info>
  <brief_title>Arrhythmia Prevention With an Alpha-Linolenic Enriched Diet</brief_title>
  <official_title>Secondary Prevention of Atrial Fibrillation With an Alpha-Linolenic Enriched Diet : a Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <brief_summary>
    <textblock>
      An alpha linolenic acid (ALA) rich diet in the Lyon Diet Heart Study reduced sudden cardiac
      deaths possibly by reducing cardiac arrhythmias and ventricular fibrillation (Lancet 1994).

      Since then, there has been a growing interest in ALA, ω-3 fatty acid family precursor, as a
      cardioprotective nutrient. Much of the interest has focused on the potential antiarrhythmic
      effect of longer chain ω-3 fatty acids, DHA and EPA, derived from fish.

      We therefore concluded it important to test wether vegetable source ω-3 also had
      antiarrhythmic effects, as shown in animals by Leaf and McLennan, since this might also
      explain the beneficial effects seen on cardiovascular mortality in the Lyon Diet Heart Study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To determine the effect of an ALA rich diet in reducing recurrence of atrial
      fibrillation as a further example of a cardiac arrhythmia.

      Design: Randomized parallel design efficacy study.

      Setting: Three university hospital centers in the Bordeaux region, France.

      Patients: 98 patients randomized immediately after successful atrial fibrillation electrical
      cardioversion.

      Intervention: A canola margarine and oil, versus a conventional diet (control), with a one
      year follow-up.

      Main outcome measure: Length of time to first recurrence of atrial fibrillation.

      Significance: If ALA is antiarrhythmic, this action may explain its cardioprotective effect
      in clinical trials and cohort studies.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 1999</start_date>
  <completion_date>June 2003</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of recurrence on periods</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of time to first recurrence of atrial fibrillation</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>subgroup analysis (high blood pressure, non persistent atrial fibrillation)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comparison between late and early recurrence (before or after 14 days)</measure>
  </secondary_outcome>
  <enrollment>130</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Diet Therapy</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Alpha-linolenic enriched diet</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients hospitalized in one of the three centers in the Bordeaux region

          -  clinical diagnosis of atrial fibrillation

          -  who subsequently underwent successful electrical cardioversion

        Exclusion Criteria:

          -  unable to receive electrical cardioversion

          -  already enrolled in another trial

          -  unable or unwilling to comply with the diet recommendations (experimental or control)
             or follow-up requirements

          -  clinically significant cardiac disease, advanced heart failure, cardiac cachexia

          -  thyroid disease, treated or untreated,

          -  clinically significant hepatic or renal disease

          -  history of malignant disease

          -  alcohol abuse

          -  taking ALA rich foods or recording intakes of ALA &gt;2g/d on the control diet or
             reporting using &lt;1g/d on the ALA diet was considered a major deviation from the
             protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>77 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Paul Broustet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitary Hospital Haut-Lévêque Bordeaux France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Serge C Renaud, VMD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Bordeaux2 University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominique Lanzmann-Petithory, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Bordeaux2 University - Paris AP Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Girac Hospital</name>
      <address>
        <city>Angouleme</city>
        <zip>16470</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital du Haut-Lévêque</name>
      <address>
        <city>Bordeaux</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert Boulin Hospital</name>
      <address>
        <city>Libourne</city>
        <zip>33500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994 Jun 11;343(8911):1454-9. Erratum in: Lancet 1995 Mar 18;345(8951):738.</citation>
    <PMID>7911176</PMID>
  </reference>
  <reference>
    <citation>Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, Martin JL, Monjaud I, Salen P, Toubol P. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995 Jun;61(6 Suppl):1360S-1367S. doi: 10.1093/ajcn/61.6.1360S.</citation>
    <PMID>7754988</PMID>
  </reference>
  <reference>
    <citation>Renaud S, Nordøy A. &quot;Small is beautiful&quot;: alpha-linolenic acid and eicosapentaenoic acid in man. Lancet. 1983 May 21;1(8334):1169.</citation>
    <PMID>6133188</PMID>
  </reference>
  <reference>
    <citation>Lanzmann-Petithory D, Pueyo S, Renaud S. Primary prevention of cardiovascular diseases by alpha-linolenic acid. Am J Clin Nutr. 2002 Dec;76(6):1456; author reply 1456-7. doi: 10.1093/ajcn/76.6.1456.</citation>
    <PMID>12450919</PMID>
  </reference>
  <reference>
    <citation>Renaud SC, Lanzmann-Petithory D. alpha-linolenic acid in the prevention of cardiovascular diseases. World Rev Nutr Diet. 2001;88:79-85. Review.</citation>
    <PMID>11935975</PMID>
  </reference>
  <reference>
    <citation>Renaud SC, Lanzmann-Petithory D. The beneficial effect of alpha-linolenic acid in coronary artery disease is not questionable. Am J Clin Nutr. 2002 Oct;76(4):903-4; author reply 904-6.</citation>
    <PMID>12324307</PMID>
  </reference>
  <reference>
    <citation>Singh RB, Dubnov G, Niaz MA, Ghosh S, Singh R, Rastogi SS, Manor O, Pella D, Berry EM. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet. 2002 Nov 9;360(9344):1455-61.</citation>
    <PMID>12433513</PMID>
  </reference>
  <reference>
    <citation>Lanzmann-Petithory D. Alpha-linolenic acid and cardiovascular diseases. J Nutr Health Aging. 2001;5(3):179-83. Review.</citation>
    <PMID>11458289</PMID>
  </reference>
  <reference>
    <citation>Kang JX, Leaf A. Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes. Eur J Pharmacol. 1996 Feb 15;297(1-2):97-106.</citation>
    <PMID>8851173</PMID>
  </reference>
  <reference>
    <citation>McLennan PL, Dallimore JA. Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. J Nutr. 1995 Apr;125(4):1003-9.</citation>
    <PMID>7722678</PMID>
  </reference>
  <verification_date>December 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 11, 2006</study_first_submitted>
  <study_first_submitted_qc>December 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2006</study_first_posted>
  <last_update_submitted>December 11, 2006</last_update_submitted>
  <last_update_submitted_qc>December 11, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2006</last_update_posted>
  <keyword>alpha linolenic acid</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>omega 3 fatty acids</keyword>
  <keyword>diet</keyword>
  <keyword>rapeseed oil</keyword>
  <keyword>canola oil</keyword>
  <keyword>cardiovascular diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

